← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 5, 2007Last known activity
May 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 7 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT06056349Reponsible party - principal investigatorN/AMay 1, 2023
- NCT06056349Sponsor investigatorN/AMay 1, 2023
- NCT06056349Lead sponsorN/AMay 1, 2023
- NCT04780152Reponsible party - principal investigatorPhase 2/Phase 3Oct 31, 2021
- NCT04780152Lead sponsorPhase 2/Phase 3Oct 31, 2021
- NCT04513184CollaboratorPhase 2Jul 14, 2020
- NCT03865121Overall official - principal investigatorPhase 2Mar 4, 2019
- NCT03865121Lead sponsorPhase 2Mar 4, 2019
- NCT03865121Reponsible party - principal investigatorPhase 2Mar 4, 2019
- NCT03204500Reponsible party - principal investigatorPhase 2May 31, 2016
- NCT03204500Lead sponsorPhase 2May 31, 2016
- NCT01144650CollaboratorPhase 2/Phase 3Jul 1, 2009
- NCT05131295Lead sponsorPhase 3Sep 5, 2007
- NCT05131295Overall official - principal investigatorPhase 3Sep 5, 2007
Details
- Last known activity
- May 1, 2023